| US 7,595,343 B2 | ||
| Inhibitors of histone deacetylase | ||
| Daniel Delorme, St-Lazare (Canada); Soon Hyung Woo, Foster City, Calif. (US); Arkadii Vaisburg, Kirkland (Canada); Oscar Moradei, Kirkland (Canada); Silvana Leit, Kirkland (Canada); Stephane Raeppel, Pierrefonds (Canada); Sylvie Frechette, Lachine (Canada); and Giliane Bouchain, Beaconsfield (Canada) | ||
| Assigned to MethylGene, Inc., Quebec (Canada) | ||
| Filed on Sep. 12, 2002, as Appl. No. 10/242,304. | ||
| Claims priority of provisional application 60/391728, filed on Jun. 26, 2002. | ||
| Claims priority of provisional application 60/322402, filed on Sep. 14, 2001. | ||
| Prior Publication US 2004/0106599 A1, Jun. 03, 2004 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. C07C 211/51 (2006.01); C07D 239/24 (2006.01); C07D 239/72 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 409/12 (2006.01); C07D 405/12 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61K 31/53 (2006.01); A61K 31/136 (2006.01); A61K 31/166 (2006.01); A61P 35/00 (2006.01) | ||
| U.S. Cl. 514—617 [564/155; 564/161; 549/59; 549/68; 549/362; 549/434; 544/50; 544/196; 544/113; 544/353; 544/358; 544/264; 544/283; 544/49; 544/90; 544/105; 544/180; 544/359; 546/139; 546/268.1; 546/452; 548/143; 548/146; 548/152; 548/217; 548/250; 514/224.2; 514/230.5; 514/231.2; 514/231.5; 514/245; 514/252.12; 514/252.13; 514/263.1; 514/266.1; 514/307; 514/336; 514/340; 514/342; 514/364; 514/367; 514/375; 514/394; 514/406; 514/456; 514/469; 514/415; 514/438; 514/443] | 15 Claims |
1. A compound of structural formula (2a):
![]() or a pharmaceutically acceptable salt thereof, wherein
Ara is phenyl or thienyl;
R6 is H, or C1-C6-alkyl;
Y and Z are —CH═;
W is (V′-L4)t-V-L3-;
L3 is a direct bond, —C1-C6-hydrocarbyl, —(C1-C3-hydrocarbyl)m1-X′—(C1-C3-hydrocarbyl)m2, —NH—(C0-C3-hydrocarbyl), (C1-C3- hydrocarbyl)-NH—, or —NH—(C1-C3-hydrocarbyl)-NH—;
m1 and m2 are independently 0 or 1;
X′ is —N(R21)—, —C(O)N(R21)—, N(R21)C(O)—, —O—, or —S—;
R21 is —H, V″—(C1-C6-hydrocarbyl)c;
L4 is (C1-C6-hydrocarbyl)a-M-(C1-C6-hydrocarbyl)b;
a and b are independently 0 or 1;
M is —NH—, —NHC(O)—, —C(O)NH—, —C(O)—, —SO2—, —NHSO2—, or —SO2NH—
V, V′, and V″ are independently selected from cycloalkyl, heterocyclyl, aryl, and heteroaryl;
t is 0 or 1;
or W, the annular C to which it is bound, and Y together form a monocyclic cycloalkyl, heterocyclyl, aryl, or heteroaryl;
and
wherein the A and Ara rings are optionally further substituted with from 1 to 3 substituents independently selected from methyl, hydroxy, methoxy,
halo, and amino.
|